The expression of CD36 in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model

被引:18
|
作者
Ueno, M. [1 ]
Nakagawa, T. [4 ]
Nagai, Y. [4 ]
Nishi, N. [4 ]
Kusaka, T. [5 ]
Kanenishi, K. [2 ]
Onodera, M. [1 ]
Hosomi, N. [6 ]
Huang, C. [7 ]
Yokomise, H. [3 ]
Tomimoto, H. [8 ]
Sakamoto, H. [1 ]
机构
[1] Kagawa Univ, Fac Med, Dept Pathol & Host Def, Miki, Kagawa 7610793, Japan
[2] Kagawa Univ, Fac Med, Dept Perinatol & Gynecol, Miki, Kagawa 7610793, Japan
[3] Kagawa Univ, Fac Med, Dept Gen Thorac Surg, Miki, Kagawa 7610793, Japan
[4] Kagawa Univ, Fac Med, Life Sci Res Ctr, Miki, Kagawa 7610793, Japan
[5] Kagawa Univ, Fac Med, Maternal & Perinatal Ctr, Miki, Kagawa 7610793, Japan
[6] Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan
[7] Kyoto Univ, Fac Med, Dept Thorac Surg, Kyoto, Japan
[8] Mie Univ, Grad Sch Med, Dept Neurol, Tsu, Mie 514, Japan
关键词
blood-brain barrier; CD36; hypertension; SHRSP; LOW-DENSITY-LIPOPROTEIN; B SCAVENGER RECEPTOR; AMYLOID-BETA; LDL RECEPTOR; OXIDANT STRESS; PROTEIN; RATS; HIPPOCAMPUS; PEPTIDE; OVEREXPRESSION;
D O I
10.1111/j.1365-2990.2011.01172.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aims: The class B scavenger receptor CD36, the receptor for oxidized low-density lipoprotein, mediates free radical production and brain injury in cerebral ischaemia. Free radical production is known to be involved in the remodelling of the cerebral vasculature of stroke-prone spontaneously hypertensive rats (SHRSP). Accordingly, we examined whether the expression of CD36 is increased in the vasculature with blood-brain barrier (BBB) impairment and collagen deposition of SHRSP. Methods: The gene and protein expression of CD36 was examined in the vessels of the hippocampus of SHRSP with BBB impairment and those of Wistar Kyoto rats without the impairment, by real-time RT-PCR, Western blotting and immunohistochemical techniques. Results: The gene and protein expression of CD36 was increased in the hippocampus of SHRSP compared with that of Wistar Kyoto rats. Confocal microscopic examination revealed CD36 immunoreactivity in perivascular microglial cells immunopositive for ED1. Immunoelectron microscopic examination revealed that the immunosignals for CD36 were located mainly in the cytoplasm of perivascular cells in vessels showing increased vascular permeability and a few in the cytoplasmic membranes of endothelial cells. Conclusions: These findings indicate that the expression of CD36 was increased in vessels with BBB impairment in the hippocampus of SHRSP and was mainly seen in the cytoplasm of perivascular microglial cells, suggesting a role of CD36 in cerebrovascular injury.
引用
收藏
页码:727 / 737
页数:11
相关论文
共 50 条
  • [21] Impairment and restoration of the endothelial blood-brain barrier in the rat cerebral infarction model assessed by expression of endothelial barrier antigen immunoreactivity
    Nishigaya, K
    Yagi, S
    Sato, T
    Kanemaru, K
    Nukui, H
    ACTA NEUROPATHOLOGICA, 2000, 99 (03) : 231 - 237
  • [22] The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier
    Neuhaus, Winfried
    Gaiser, Fabian
    Mahringer, Anne
    Franz, Jonas
    Riethmueller, Christoph
    Foerster, Carola
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
  • [23] Inhibition of NAD(P)H oxidase reduces fibronectin expression in stroke-prone renovascular hypertensive rat brain
    Cui, Chunmei
    Chen, Alex F.
    Jiang, Zongpei
    Wu, Qingqing
    Lin, Jianwen
    Wen, Hongmei
    Zeng, Jinsheng
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2007, 34 (04) : 304 - 309
  • [24] Loss of integrity: Impairment of the blood-brain barrier in heavy metal-associated ischemic stroke
    Kim J.-H.
    Byun H.-M.
    Chung E.-C.
    Chung H.-Y.
    Bae O.-N.
    Toxicological Research, 2013, 29 (3) : 157 - 164
  • [25] An In Vivo Assessment of Blood-Brain Barrier Disruption in a Rat Model of Ischemic Stroke
    Panahpour, Hamdollah
    Farhoudi, Mehdi
    Omidi, Yadollah
    Mahmoudi, Javad
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (133):
  • [26] Subtractive expression cloning reveals high expression of CD46 at the blood-brain barrier
    Shusta, EV
    Zhu, CN
    Boado, RJ
    Pardridge, WM
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (07) : 597 - 604
  • [27] Stepwise impairment of neural stem cell proliferation and neurogenesis concomitant with disruption of blood-brain barrier in recurrent ischemic stroke
    Lin, Ruihe
    Lang, Michael
    Heinsinger, Nicolette
    Stricsek, Geoffrey
    Zhang, Justine
    Iozzo, Renato
    Rosenwasser, Robert
    Iacovitti, Lorraine
    NEUROBIOLOGY OF DISEASE, 2018, 115 : 49 - 58
  • [28] Cerebral blood volume affects blood-brain barrier integrity in an acute transient stroke model
    Huang, Shuning
    Kim, Jeong Kon
    Atochin, Dmitriy N.
    Farrar, Christian T.
    Huang, Paul L.
    Suh, Ji Yeon
    Kwon, Seon Joo
    Shim, Woo Hyun
    Cho, Hyungjoon
    Cho, Gyunggoo
    Kim, Young Ro
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2013, 33 (06) : 898 - 905
  • [29] IFN-β regulates CD73 and adenosine expression at the blood-brain barrier
    Niemela, Jussi
    Ifergan, Igal
    Yegutkin, Gennady G.
    Jalkanen, Sirpa
    Prat, Alexander
    Airas, Laura
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (10) : 2718 - 2726
  • [30] Disrupted Blood-Brain Barrier and Mitochondrial Impairment by Autotaxin-Lysophosphatidic Acid Axis in Postischemic Stroke
    Bhattarai, Susmita
    Sharma, Sudha
    Ara, Hosne
    Subedi, Utsab
    Sun, Grace
    Li, Chun
    Bhuiyan, Md Shenuarin
    Kevil, Christopher
    Armstrong, William P.
    Minvielle, Miles T.
    Miriyala, Sumitra
    Panchatcharam, Manikandan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (18):